Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 14:16:4163-4178.
doi: 10.2147/OPTH.S393730. eCollection 2022.

Surgical Outcomes of Glaucoma Drainage Device Implantation in Refractory Glaucoma Patients in Thailand

Affiliations

Surgical Outcomes of Glaucoma Drainage Device Implantation in Refractory Glaucoma Patients in Thailand

Kulawan Rojananuangnit et al. Clin Ophthalmol. .

Abstract

Purpose: To study the surgical outcomes of glaucoma drainage device (GDD) implantation in refractory glaucoma patients.

Patients and methods: Retrospective chart review of glaucoma patients undergoing GDD implantation, Ahmed glaucoma valve (AGV), Baerveldt glaucoma implants (BGI), and Aurolab aqueous drainage implantation (AADI) from January 2012 to June 2021. Glaucoma patients were classified into two groups: primary glaucoma including: primary open angle glaucoma (POAG), primary angle closure glaucoma (PACG) and juvenile open angle glaucoma (JOAG) and secondary glaucoma including: neovascular glaucoma (NVG), ocular surgery (vitreoretinal surgery, scleral buckling procedure, postoperative extra capsular cataract extraction, scleral fixation intraocular lens, penetrating keratoplasty), intraocular trauma, uveitis glaucoma, lens-induced glaucoma, pseudoexfoliation glaucoma (PXG), iridocorneal endothelial (ICE) syndromes and Axenfeld Rieger Syndrome. Surgical outcomes were studied.

Results: Primary glaucoma included 57 eyes from 49 patients. Secondary glaucoma included 87 eyes from 85 patients. The cumulative probability of complete or qualified success of refractory glaucoma patients at five years were 53.4% (95%CI: 38.4%, 66.3%). Higher success rate was discovered in primary glaucoma at 65.8% (95%CI: 38.4%, 83.3%) than 45.2% (95%CI: 26.9%, 61.9%) in secondary glaucoma group significantly with p=0.003. While the results among success rate, adverse events and complications was not different between types of GDD. Predictors for failure were neovascular glaucoma with unadjusted hazard ratio (HR) 3.62 (95%CI: 1.45, 9.04) with p=0.006, and lens-induced glaucoma with adjusted HR 4.19 (95%CI: 1.10, 15.86) with p=0.035 in multivariable analysis. Tube malposition and occlusion were the most frequent adverse events at 11.11%, corneal decompensation at 5.5%, hypotony at 2% in the nonvalved group, and endophthalmitis at 0.69%.

Conclusion: Surgical success in refractory primary glaucoma was superior to secondary glaucoma with no difference between nonvalved and valved GDD implantation. Lens-induced glaucoma was a strong predictor for failure in GDD implantation.

Keywords: glaucoma drainage device; primary glaucoma; refractory glaucoma; secondary glaucoma.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Kaplan–Meier survival curve showing the cumulative probability of complete or qualified success comparing between primary and secondary glaucoma.
Figure 2
Figure 2
Kaplan–Meier survival curve showing the cumulative probability of complete or qualified success comparing between valved and nonvalved glaucoma drainage device.
Figure 3
Figure 3
Mean intraocular pressure (IOP) of primary glaucoma and secondary glaucoma groups at baseline and follow-up. (*p<0.001 compared with preoperative).
Figure 4
Figure 4
Average number of antiglaucoma medications of primary glaucoma and secondary glaucoma groups at baseline and follow-up. (*p<0.001 compared with preoperative).

Similar articles

Cited by

References

    1. Dawson EF, Rosenberg NC, Meyer AM, et al. Comparison of outcomes of glaucoma drainage implant surgery with or without prior failed trabeculectomy. J Glaucoma. 2021;30(7):585–595. doi:10.1097/ijg.0000000000001852 - DOI - PubMed
    1. Kornmann HL, Gedde SJ. Glaucoma management after vitreoretinal surgeries. Curr Opin Ophthalmol. 2016;27(2):125–131. doi:10.1097/icu.0000000000000238 - DOI - PMC - PubMed
    1. Knape RM, Szymarek TN, Tuli SS, Driebe WT, Sherwood MB, Smith MF. Five-year outcomes of eyes with glaucoma drainage device and penetrating keratoplasty. J Glaucoma. 2012;21(9):608–614. doi:10.1097/IJG.0b013e31821db3e5 - DOI - PMC - PubMed
    1. Yang H, Yu X, Sun X. Neovascular glaucoma: handling in the future. Taiwan J Ophthalmol. 2018;8(2):60–66. doi:10.4103/tjo.tjo_39_18 - DOI - PMC - PubMed
    1. Clement CI, Goldberg I. The management of complicated glaucoma. Indian J Ophthalmol. 2011;59:S141–7. doi:10.4103/0301-4738.73686 - DOI - PMC - PubMed

LinkOut - more resources